ECS Stock Overview
ECS Botanics Holdings Ltd engages in the cultivation, manufacture, and sale of medicinal cannabis products in Northwest Victoria.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
ECS Botanics Holdings Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.022 |
| 52 Week High | AU$0.031 |
| 52 Week Low | AU$0.017 |
| Beta | 1.27 |
| 1 Month Change | -12.00% |
| 3 Month Change | 0% |
| 1 Year Change | 10.00% |
| 3 Year Change | -53.19% |
| 5 Year Change | n/a |
| Change since IPO | -66.15% |
Recent News & Updates
Shareholder Returns
| ECS | AU Pharmaceuticals | AU Market | |
|---|---|---|---|
| 7D | 0% | -3.0% | -2.2% |
| 1Y | 10.0% | 37.1% | 4.5% |
Return vs Industry: ECS underperformed the Australian Pharmaceuticals industry which returned 37.1% over the past year.
Return vs Market: ECS exceeded the Australian Market which returned 4.5% over the past year.
Price Volatility
| ECS volatility | |
|---|---|
| ECS Average Weekly Movement | 8.9% |
| Pharmaceuticals Industry Average Movement | 11.1% |
| Market Average Movement | 9.0% |
| 10% most volatile stocks in AU Market | 17.6% |
| 10% least volatile stocks in AU Market | 3.4% |
Stable Share Price: ECS has not had significant price volatility in the past 3 months.
Volatility Over Time: ECS's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Nan-Maree Schoerie | www.ecs-botanics.com |
ECS Botanics Holdings Ltd engages in the cultivation, manufacture, and sale of medicinal cannabis products in Northwest Victoria. The company is involved in the agriculture business. ECS Botanics Holdings Ltd is based in Murrabit, Australia.
ECS Botanics Holdings Ltd Fundamentals Summary
| ECS fundamental statistics | |
|---|---|
| Market cap | AU$27.70m |
| Earnings (TTM) | AU$2.49m |
| Revenue (TTM) | AU$19.87m |
11.4x
P/E Ratio1.4x
P/S RatioIs ECS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ECS income statement (TTM) | |
|---|---|
| Revenue | AU$19.87m |
| Cost of Revenue | AU$11.73m |
| Gross Profit | AU$8.14m |
| Other Expenses | AU$5.65m |
| Earnings | AU$2.49m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.0019 |
| Gross Margin | 40.95% |
| Net Profit Margin | 12.53% |
| Debt/Equity Ratio | 0% |
How did ECS perform over the long term?
See historical performance and comparison